According to recent reports from Russian media, India emerged as the largest pharmaceutical supplier to Russia in 2023, replacing the previously dominant Western companies.
Indian pharmaceutical companies are currently focused on developing flagship products or mother brands. These are designed to incorporate various new combinations and ensure robust revenue growth and therapy leadership.
The National Institute of Mental Health and Neuro Sciences (NIMHANS) recently displayed Electroconvulsive, which is considered to be one of the earliest medical treatments that has shown reasonable effectiveness in treating severe
Dr. Kuldeep Sachdeva, President and Chief Medical Officer (CMO) of Molbio Diagnostics, has emphasized implementing national essential diagnostic guidelines in India to revolutionize healthcare delivery.
Intuitive medical device firm and the innovation leader in minimally invasive care has secured the US FDA endorsement for da Vinci 5, the organization's cutting-edge multiport robotic system. “We are pleased to receive...
Pharmaceutical and healthcare firm Sanofi announced an exclusive distribution with Cipla for their Central Nervous System (CNS) product line in India. Because of this partnership, Cipla will deal with disseminating Sanofi India's six CNS brands...
Astellas Pharma Inc., based in Tokyo, reported the other day Japan's Ministry of Health, Labour and Welfare approved VYLOYâ„¢ (zolbetuximab), an anti-claudin 18.2 (CLDN18.2) monoclonal neutralizer for patients with CLDN18.2 positive, unresectable...
The department of pharmaceuticals (DoP) has framed with another arrangement of rigid marketing code for the pharma organizations. Uniform Code for Drug Showcasing Practices (UCPMP) 2024 is the new code and is “mandatory†and would supplant the...
The Indian Institute of Technology Guwahati has achieved a significant milestone by successfully transferring a groundbreaking vaccine technology to BioMed Pvt. Ltd., a renowned manufacturer specializing in high-quality vaccines.This innovative ...
Verge Genomics, a leading biotechnology firm, has declared a partnership with Ferrer to co-foster VRG50635, Verge’s lead candidate, for the treatment of irregular and familial types of amyotrophic lateral sclerosis (ALS) in Europe, Central and...
, CDSCO.jpg)
